Propel Bio Management, LLC has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $82.4 Billion distributed in 16 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Plains Gp Holdings LP with a value of $24.7B, Achieve Life Sciences Inc with a value of $13.9B, Akero Therapeutics, Inc. with a value of $12.2B, Phathom Pharmaceuticals, Inc. with a value of $8.85B, and Abeona Therapeutics Inc. with a value of $5.53B.

Examining the 13F form we can see an decrease of $3.68B in the current position value, from $86.1B to 82.4B.

Propel Bio Management, LLC is based out at Los Angeles, CA

Below you can find more details about Propel Bio Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $82.4 Billion
Healthcare: $42.9 Billion
Energy: $24.7 Billion

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 16
  • Current Value $82.4 Billion
  • Prior Value $86.1 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 13, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 2 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Propel Bio Management, LLC Portfolio

Follow Propel Bio Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Propel Bio Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Propel Bio Management, LLC with notifications on news.